Statistics
Publications
27
Citations
1.7K
H-Index
22
Active since
2000
Eric Vangrevelinghe is an author at Novartis (Switzerland) specializing in drug discovery, pharmacology, and medicinal chemistry.
Publications per year
2000–2024
27
27
A Small-Molecule Dengue Virus Entry Inhibitor
Qingyin Wang, Sejal Patel, Eric Vangrevelinghe et al. · Antimicrobial Agents and Chemotherapy · 2009 · 208 citations · Full text
Genetic resistance to JAK2 enzymatic inhibitors is overcome by HSP90 inhibition
Oliver Weigert, Andrew A. Lane, Liat Bird et al. · The Journal of Experimental Medicine · 2012 · 162 citations · Full text
Medicine, Oncology, Pharmacology +14
Activity of the Type II JAK2 Inhibitor CHZ868 in B Cell Acute Lymphoblastic Leukemia
Shuo-Chieh Wu, Loretta S. Li, Nadja Kopp et al. · Cancer Cell · 2015 · 123 citations · Full text
Medicine, Oncology, Pharmacology +8
1–5 of 27